The effect of antithymocyte globulin therapy on frequency and avidity of allospecific committed CTL in clinical heart transplants.
Baan
C C
CC
Department of Internal Medicine, University Hospital Rotterdam-Dijkzigt, The Netherlands.
Vaessen
L M
LM
Loonen
E H
EH
Balk
A H
AH
Jutte
N H
NH
Claas
F H
FH
Weimar
W
W
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D000915:Antibody Affinity; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001706:Biopsy; D016827:CD8 Antigens / Q000276:immunology; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D006084:Graft Rejection / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007518:Isoantibodies / Q000276:immunology; D011817:Rabbits; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000473:pathology; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D016827:CD8 Antigens; D007518:Isoantibodies